Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease

NCT05229614 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer
Head and Neck Squamous Cell Carcinoma
Melanoma
Urothelial Carcinoma

Interventions

RADIATION: Carbon Ion Therapy
DRUG: Immunotherapy (Pembrolizumab)

Sponsor

CNAO National Center of Oncological Hadrontherapy

Collaborators

[object Object]
[object Object]
[object Object]